Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus

Clinical and Experimental Immunology

Volumn 159, Issue 1, 2010, Pages 11-22

  Wong, C K ^a   Wong, P T Y ^a   Tam, L S ^a   Li, E K ^a   Chen, D P ^a   Lam, C W K ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

Cytokines; Systematic lupus erythematosus; Toll like receptors

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INNATE IMMUNITY; MONOCYTE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AMINOQUINOLINES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; DINUCLEOSIDE PHOSPHATES; FEMALE; FLAGELLIN; HUMANS; IMMUNITY, INNATE; INTERFERON INDUCERS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MONOCYTES; PEPTIDOGLYCAN; POLY I-C; RNA; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 70749147183     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04036.x     Document Type: Article

References (41)

1. Yamamoto M, Sato S, Hemmi H et al. Role of adapter TRIF in the myd88-independent Toll-like receptor signaling pathway. Science 2003 301 : 640 643. (Pubitemid 36927946)
2. Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann NY Acad Sci 2008 1143 : 21 34.
3. O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev 2008 226 : 10 18.
4. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003 21 : 335 376.
5. Ehlers M, Fukuyama H, McGaha TL, Aderem A, Ravetch JV. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 2006 203 : 553 561.
6. Poeck H, Wagner M, Battiany J et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 2004 103 : 3058 3064.
7. Heit A, Huster KM, Schmitz F, Schiemann M, Busch DH, Wagner H. CpG-DNA aided cross-priming by cross-presenting B cells. J Immunol 2004 172 : 1501 1507.
8. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001 2 : 947 950. (Pubitemid 32976167)
9. Redecke V, Hacker H, Datta SK et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004 172 : 2739 2743.
10. Didierlaurent A, Ferrero I, Otten LA et al. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol 2004 172 : 6922 6930.
11. Sadanaga A, Nakashima H, Akahoshi M et al. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum 2007 56 : 1618 1628.
12. Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 2007 18 : 1721 1731.
13. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006 25 : 417 428.
14. Papadimitraki ED, Choulaki C, Koutala E et al. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum 2006 54 : 3601 3611.
15. Komatsuda A, Wakui H, Iwamoto K et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol 2008 152 : 482 487.
16. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 25 : 1271 1277.
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992 35 : 630 640.
18. Lun SW, Wong CK, Ko FW, Hui DS, Lam CW. Expression and functional analysis of Toll-like receptors of peripheral blood cells in asthmatic patients: implication for immunopathological mechanism in asthma. J Clin Immunol 2009 29 : 330 342.
19. Kulkarni O, Anders HJ. Chemokines in lupus nephritis. Front Biosci 2008 13 : 3312 3320.
20. Lourenço EV, La Cava A. Cytokines in systemic lupus erythematosus. Curr Mol Med 2009 9 : 242 254.
21. Abdollahi-Roodsaz S, Joosten LA, Koenders MI et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008 118 : 205 216.
22. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF et al. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 2007 56 : 2957 2967.
23. Kattah MG, Wong MT, Yocum MD, Utz PJ. Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells. Arthritis Rheum 2008 58 : 1619 1629.
24. Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 2008 127 : 385 393.
25. Eis V, Luckow B, Vielhauer V et al. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 2004 15 : 337 347.
26. Moore KJ, Wada T, Barbee SD, Kelley VR. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice. Kidney Int 1998 53 : 1631 1641.
27. Stahl RA, Thaiss F, Disser M, Helmchen U, Hora K, Schlöndorff D. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 1993 44 : 1036 1047.
28. Chan RW, Tam LS, Li EK et al. Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 2003 48 : 1326 1331.
29. Lit LC, Wong CK, Tam LS, Li EK, Lam CW. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006 65 : 209 215.
30. Demirci FY, Manzi S, Ramsey-Goldman R et al. Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol 2007 34 : 1708 1711.
31. Ma Z, Chen F, Madaio MP, Cohen PL, Eisenberg RA. Modulation ofautoimmunity by TLR9 in the chronic graft-vs-host model of systemic lupus erythematosus. J Immunol 2006 177 : 7444 7450.
32. Pawar RD, Patole PS, Ellwart A et al. Ligands to nucleic acid-specific Toll-like receptors and the onset of lupus nephritis. J Am Soc Nephrol 2006 17 : 3365 3373.
33. Migita K, Miyashita T, Maeda Y et al. Toll-like receptor expression in lupus peripheral blood mononuclear cells. J Rheumatol 2007 34 : 493 500.
34. Nakano S, Morimoto S, Suzuki J et al. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology 2008 47 : 145 149.
35. Zorro S, Arias M, Riaño F et al. Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity. Lupus 2009 18 : 718 726.
36. Peng G, Guo Z, Kiniwa Y et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005 309 : 1380 1384.
37. Yang J, Chu Y, Yang X et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009 60 : 1472 1483.
38. Vollmer J, Tluk S, Schmitz C et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005 202 : 1575 1585.
39. Patole PS, Grone HJ, Segerer S et al. Viral doublestranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 2005 16 : 1326 1338.
40. Kim WU, Sreih A, Bucala R Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun Rev 2009 8 : 204 208.
41. Barrat FJ, Coffman RL Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol Rev 2008 223 : 271 283.